Eu Ivdd Eu Ivd Annex 2 List A On The Market

ALBAcheck®

Devices (same UDI-DI)
1
Certificates
2
Countries
12
Notified Bodies
2

Basic Information

Primary DI
05060242470820
Basic UDI-DI Code
B-05060242470820
Reference
Z489
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List A
Status
On The Market

Additional Description

ALBAcheck-BGS Simulated Whole Blood Controls have been prepared from red blood cells collected from blood donors. Each individual vial contains known ABO, Rh and K blood group antigens plus ABO and irregular blood group antibodies listed below. Red blood cells are of human origin. ABO and Anti-D antibodies are of monoclonal origin and Anti-K antibodies are of polyclonal origin. Vial 1- Group A, R1R1, K positive containing Anti-B. Vial 2- Group B, R1R2, K negative containing Anti-A and Anti-K. Vial 3- Group O, R2R2, K negative containing Anti-A and Anti-B. Vial 4 - Group AB, rr, K negative containing Anti-D. The concentration of red cells in each of the vials has been adjusted to 15±2%. The red cells are suspended in a preservative solution to retard haemolysis and bacterial contamination.

CND Nomenclature Codes

Code Description
W0103030402 CONTROL KITS (IMMUNOHAEMATOLOGY)

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) 1434-IVDD-121/2022
IVDD Annex IV Section 4 1434-IVDD-120/2022

Available In Countries

🇦🇹 Austria 🇨🇿 Czechia 🇩🇪 Germany 🇬🇷 Greece 🇮🇪 Ireland 🇮🇹 Italy 🇱🇺 Luxembourg 🇳🇱 Netherlands 🇷🇴 Romania 🇸🇪 Sweden 🇸🇰 Slovakia 🇬🇧 United Kingdom

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List A) and regulation (EU IVDD).

View all